Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2025-12-24 @ 7:14 PM
NCT ID:
NCT04192903
Brief Title:
Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer
Official Title:
Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer
Study:
NCT04192903
Protocol Section:
NCT04192903